Press Releases

Show events starting after a certain date ( i.e. YYYY-MM-DD)
Show events starting before a certain date ( i.e. YYYY-MM-DD)
There are currently no events to display.
Dec 5 2017
Summary ToggleAdverum Biotechnologies Begins Patient Enrollment in the ADVANCE Phase 1/2 Clinical Trial for A1AT Deficiency  
Nov 15 2017
Summary ToggleAdverum Biotechnologies to Present at Upcoming Conferences  
Nov 8 2017
Summary ToggleAdverum Biotechnologies Reports Third Quarter 2017 Financial Results and Provides Corporate Update  
Oct 2 2017
Summary ToggleAdverum Biotechnologies Appoints Linda Neuman, M.D. as Vice President, Clinical Development  
Sep 28 2017
Summary ToggleAdverum Biotechnologies to Present at Upcoming Conferences  
Sep 27 2017
Summary ToggleAdverum Biotechnologies Presents Updated Preclinical Data on ADVM-022 in Wet AMD at the 2017 Targeting Ocular Disorders Conference  
Sep 7 2017
Summary ToggleAdverum Biotechnologies Appoints Eric G. Carter, M.D., Ph.D. to Board of Directors  
Sep 7 2017
Summary ToggleAdverum Biotechnologies to Present at BioCentury’s 24th Annual NewsMakers in the Biotech Industry Conference  
Aug 8 2017
Summary ToggleAdverum Biotechnologies Reports Second Quarter 2017 Financial Results and Provides Update  
Jun 20 2017
Summary ToggleAdverum Biotechnologies, Inc. Announces Appointment of Athena Countouriotis, M.D. as SVP and Chief Medical Officer  
May 22 2017
Summary ToggleAdverum Biotechnologies to Present at the Jefferies Global Healthcare Conference  
May 10 2017
Summary ToggleAdverum Biotechnologies, Inc. Announces Data Presentations at the ARVO and ASGCT 2017 Annual Meetings  
May 9 2017
Summary ToggleAdverum Biotechnologies Reports First Quarter 2017 Financial Results and Provides Update  
Apr 20 2017
Summary ToggleAdverum Biotechnologies, Inc. Appoints Richard N. Spivey, Pharm.D., Ph.D. to Board of Directors  
Apr 17 2017
Summary ToggleAdverum Biotechnologies Announces Updated Presentation Time for ARM 5th Annual Cell & Gene Therapy Investor Day  
Apr 6 2017
Summary ToggleAdverum Biotechnologies to Present at the ARM 5th Annual Cell & Gene Therapy Investor Day  
Mar 14 2017
Summary ToggleAdverum Biotechnologies, Inc. Appoints Patrick Machado, J.D. to Board of Directors  
Mar 6 2017
Summary ToggleAdverum Biotechnologies Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Update  
Feb 21 2017
Summary ToggleAdverum Biotechnologies to Present at Upcoming Investor Conferences  
Jan 18 2017
Summary ToggleAdverum Biotechnologies to Present At Phacilitate Cell & Gene Therapy World 2017